• Be A Partner
  • Social Responsibility
    • Students Training
  • IR
    • Investor Relations
    • Financial Charts
    • Annual Reports
  • News
    • PRESS RELEASES
    • SOCIAL EVENTS
    • CONFERENCES
  • Careers
  • Covid-19
  • Report a side effect
  • Contact Us
    • Branches
  • Home
  • We are Eipico
    We are Eipico
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Uniqueness
      • WHO Approval
      • Sterile products Area
      • Automatic Ampoules Inspection
      • Eipico Ophthalmology
      • Primary packaging materials
      • Restricted-access barrier system
      • Distribution Channel
    • Our History
    • Vision, Mission & Values
    • Chairman Message
    • Eipico Employees
    • Manufacturing Facilities
    • Media Library
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Eipico Destination
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Factory 1
    • Factory 2
    • Factory 3 (Biotechnology)
    • Eiaco Factory
    • Batterjee Factory
    • EIPICO Plastic Factory
  • R&D And Quality
    R&D And Quality
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Quality Assurance
    • Quality Control
    • R&D
    • Regulatory Affairs
    • Global Accreditation
    • Track and Trace
  • Products
    Products
    EIPICO produces 400 Pharmaceutical Products covering 25 therapeutic classes and it is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Eipico Products
      • By Alphabet
  • Biotechnology
Press Releases
You are here : >>News >>Press Releases

EIPICO in cooperation with the Alliance of Greenmea & E L Square enter the era of digital transformation in pharmaceutical production " EIPICO pharma 4.0 project "

ايبيكو تشهد اكبر منظومة للتطوير والتحديث فى تاريخها

مع نهاية الربع الاول لعام 2022 فى 30 مارس
إيبيكو : تؤكد صدارتها للسوق المصرى و التصدير

Dr. Khaled Abdelghaffar during his visit to EIPICO

فوربس : « د.أحمد كيلاني » بين القادة الخمسون الأكثر تأثيرًا بقطاع الرعاية الصحية في الشرق الأوسط

Dr. Ahmed Kelani: EIPICO achieves the impossible equation in 2021

ايبيكو تقتنص صدارة سوق الدواء المصري في 2021 من حيث عدد العبوات المباعة ونسبة النمو

ايبيكو تنتج عقار كوفابرافير "مولنوبيرافير" احدث دواء للعلاج من الكورونا

د. أحمد كيلانى: 80 مليون دولار استثمارات شركة أفرى أبى لتصنيع الخامات الدوائية برأسمال مليار جنيه

Dr. Ahmed Kelani: EIPICO exports $4.7 Million to Tanzania before the end of February 2022

حوار هام جدا لجريدة أخبار اليوم - دكتور/ أحمد كيلانى رئيس مجلس الإدارة والعضو المنتدب لشركة ايبيكو للأدوية وبداية و لا اروع لعام 2022

EIPICO’s QC Labs were EGAC accredited

EIPICO : Outstanding Achievements In The first 9 Months Of 2021 Total sales 2.4 EGP Billion

بتكلفة تزيد عن 43,5 مليون دولار تمت الموافقة على اسناد انشاء مصنع ايبيكو 3

وزير الصحة بالسودان يزور شركة أيبيكو للادوية أكبر شركات أكديما

تسجيل 7 مستحضرات حيوية وبيولوجية لعلاج الأورام والروماتويد - و تصدير مستحضر ريمايست " ريمديسفير " للعراق و اقليم كردستان ، وجارى التصدير لاوغندا

شراكة بين السودان ومصر في مجال إنتاج وتصنيع الادوية بالخرطوم

EIPICO’s General Assembly renews confidence in Dr. Ahmed Kelani as a Chairman of the Board of Directors and The Managing Director

Dr. Ahmed Kelani Signs Memorandum of Understanding for joint pharmaceutical manufacturing in the Egyptian-Kazakh Business Forum.

Dr. Kelani discusses with the Ambassador of Belarus ways to support industrial cooperation and exchange experiences in all fields.

Egypt Labor Union honors Dr. Ahmed Kelani.

Dr. Ahmed Kelani – EIPICO Chairman - announced to Masrawy – Press News -That "Epifluver" the treatment for Corona patients - known internationally as Avigan – produced by EIPICO will be in Market soon.

Mr. Mohamed Saafan - Manpower Minister receives Dr. Ahmed Kelani to discuss the ways of mutual Cooperation, Social and Healthcare for EIPICO employees.

EIPICO to begin producing of “ Epifluovir “ – favipiravir- for covid-19 patients and manufacturing ” Remicovir “ - remdesivir soon.

EIPICO- Pharmaceutical Company - is standing beside home Country to confront the Corona epidemic.

General Assembly meeting of EIPICO company.

Dr. Ahmed Kelani: Political Support staying behind increasing Egyptian-Belarusian trade exchange.

Cooperation between " Federation of chambers of Commerce, and "Egyptian-Belarus Business Council" in order to expand trade exchange and establish joint investments.

EIPICO acquires 9.77% of the shares of the Medical Union Pharmaceuticals Company

EIPICO will begin construction of its new plant early next year with an investment of Billion L.E.

EIPICO is a friendly Environment company. Environment Minister visits EIPICO pharmaceutical factory and praises the advanced performance of the pharmaceuticals production stages.

During the first five months of this year, EIPICO pharmaceuticals company achieved sales growth of 19.9%, which representing 3.8% of the Egyptian pharmaceutical market.

  • ...
  • Previous
  • 1
  • 2
  • Next
  • ...
  • Pages count = 2
  • All items count = 34



WE ARE EIPICO

  • Uniqueness
  • Our History
  • Vision, Mission & Values
  • Chairman Message
  • Eipico Employees

Manufacturing Facilities

  • Factory 1
  • Factory 2
  • Factory 3
  • Eiaco Factory
  • Batterjee Factory
  • Plastic Factory

Products

  • Eipico Product
  • Eipico Products By Alphabet

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
    Visitors Count : 438944